Related Experiment Video

Updated: Mar 9, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K

Experimental Therapies for Ebola Virus Disease: What Have We Learned?

Frederick G Hayden1, Martin Friede2, Daniel G Bausch2

  • 1University of Virginia School of Medicine, Charlottesville.

The Journal of Infectious Diseases
|January 12, 2017
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Ebolaantiviralsclinical researchimmunotherapeutics

More Related Videos

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.7K
Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples
06:59

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples

Published on: June 30, 2018

7.8K

Related Experiment Videos

Last Updated: Mar 9, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K
Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.7K
Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples
06:59

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples

Published on: June 30, 2018

7.8K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

33.6K
Overview
33.6K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.7K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.7K

Articles linked to this work by shared authors, journal, and citation graph.

From Global Insights to Local Action: Bridging Vaccine Design and Manufacturing Gaps in H5N1 Pandemic Readiness.

Vaccines·2026

Antiviral Resistance in Influenza: Clinical and Public Health Implications.

Influenza and other respiratory viruses·2026

Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.

The New England journal of medicine·2026

Unpacking the mRNA Supply Chain: Challenges and Opportunities for Global Health.

Vaccines·2026

Pathways to economically viable and sustainable vaccine manufacturing in LMICs.

Vaccine·2026

Consensus on key domains for emergency medical teams deployment evaluation: a Delphi method study.

Conflict and health·2026

Inferring diagnostic serial intervals to understand COVID-19 transmission dynamics in Hong Kong and Mainland China.

The Journal of infectious diseases·2026

HPV vaccine effectiveness against prevalent HPV by age, years sexually active before vaccination, and HIV status in gay, bisexual, and other men who have sex with men, 2019-2021.

The Journal of infectious diseases·2026

Concordance Between Fingerprick and Venous Whole Blood CD4 Counts Using the Visitect CD4 Advanced disease platform.

The Journal of infectious diseases·2026

Serosurvey for Antibodies to Bourbon Virus and Related Thogotoviruses in Immunoglobulin Lots Obtained From Human Plasma Collected in the United States and Europe.

The Journal of infectious diseases·2026

Prior Dengue Virus Exposure is Associated with Enhanced Zika Virus-Specific ADCC Activity in a Longitudinal Human Cohort.

The Journal of infectious diseases·2026

A serological method's ability to distinguish treatment regimens by assessing early antibody decline in Chagas patients: insights from E1224 data.

The Journal of infectious diseases·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us